GH Research Prices $150M Public Offering
Ticker: GHRS · Form: 6-K · Filed: Feb 5, 2025 · CIK: 1855129
Sentiment: neutral
Topics: public-offering, financing, pharmaceutical
TL;DR
GH Research just raised $150M via a stock offering, closing next week.
AI Summary
GH Research PLC announced on February 4, 2025, the pricing of a public offering of its ordinary shares, raising $150 million. The offering is expected to close on February 7, 2025. Julie Ryan, Vice President of Finance, signed off on the filing.
Why It Matters
This capital raise provides GH Research with significant funding, which could be used for further research, development, or expansion of its pharmaceutical products.
Risk Assessment
Risk Level: medium — Public offerings can dilute existing shareholders and the success of the company depends on the effective use of the raised capital.
Key Numbers
- $150 million — Public Offering (Capital raised by GH Research PLC)
Key Players & Entities
- GH Research PLC (company) — Registrant
- $150 million (dollar_amount) — Public offering proceeds
- February 4, 2025 (date) — Pricing date of public offering
- February 7, 2025 (date) — Expected closing date of public offering
- Julie Ryan (person) — Vice President, Finance
FAQ
What is the purpose of the $150 million public offering?
The filing does not specify the exact use of the $150 million raised, but typically such funds are used for research, development, operations, or strategic initiatives.
When is the public offering expected to close?
The public offering is expected to close on February 7, 2025.
Who signed the 6-K report on behalf of GH Research PLC?
Julie Ryan, Vice President, Finance, signed the report on behalf of GH Research PLC.
What type of filing is this 6-K report?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the SIC code for GH Research PLC?
The Standard Industrial Classification (SIC) code for GH Research PLC is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2025-02-04 21:04:08
Filing Documents
- dp224444_6k.htm (6-K) — 9KB
- dp224444_ex9901.htm (EX-99.1) — 10KB
- 0000950103-25-001591.txt ( ) — 20KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2025. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated February 4, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: February 4, 2025 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance